Responding to COVID-19 in Africa: Using data to find a Balance (Part II)

  • Version
  • Download 4792
  • File Size 3.69 MB
  • File Count 2
  • Create Date 6 October 2020
  • Last Updated 17 November 2020

Responding to COVID-19 in Africa: Using data to find a Balance (Part II)

Executive summary: Six months into the COVID-19 pandemic, governments have had to make tough decisions
about how best to protect the public’s health first and foremost, while also safeguarding livelihoods and reducing the social harm that can come with bringing many society activities to a near halt.
Generally, African Union (AU) Member States have confirmed fewer cases per capita compared to other regions of the world. Reported cases peaked in late July and early August—driven by the epidemic in South Africa—and have since
tapered off; however, data on testing capacity indicates many cases are going undetected. This report—which is the second in the Partnership for Evidence-Based Response to COVID-19’s (PERC) “Responding to COVID-19 in Africa: Using Data to Find a Balance”—analyzes multiple data sources to help governments as they navigate the pandemic, which does not yet have an end date in sight.

 

 

 

 

Attached Files

FileAction
PERC Responding to COVID-19 in Africa - FrenchDownload
PERC Responding to COVID-19 Africa - EnglishDownload

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.

We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

Corporate author(s): Africa Centres for Disease Control and Prevention (Africa CDC); Clinton Health Access Initiative (CHAI); PATH

Publication date: October 2024

Download Files
FileAction
African Vaccine Manufacturing Mapping | Supply and Demand LandscapeDownload